About the Mass General Brigham Cancer Institute
At the Mass General Brigham Cancer Institute, we unite the expertise of two of the nation’s best hospitals—Massachusetts General Hospital and Brigham and Women’s Hospital—into one team.
Together, our team turns early detection into survival and innovation into hope. With unmatched scale, the Mass General Brigham Cancer Institute saves more lives every year. Within one integrated system, with convenient access to locations across New England, we’re here for patients at every stage — delivering comprehensive cancer care at the right time, in the right place.
855-776-4224
Call the Mass General Brigham Cancer Institute at 855-776-4224
Our difference
At the Mass General Brigham Cancer Institute, we bring together the brightest minds in cancer research and care to deliver the latest breakthroughs for patients with cancer. Experts from across our academic healthcare system unite to care for all types of cancer, from the most common to complex.
When you’re here, you benefit from:
- Early cancer detection: Detecting cancer in its early stages helps lead to better outcomes. That’s why we’re developing screening tools and technologies to improve early cancer detection and diagnosis.
- Integrated care for your whole health: We believe in treating more than just cancer—we care for the patient with cancer. Our approach addresses every aspect of a person’s health, bringing specialists from across medicine together as one team.
- Trailblazing discovery and innovation: Mass General Brigham, ranked #1 in hospital medical research in the U.S., is pushing the boundaries to develop and utilize the most advanced cancer treatments and technologies.
- Research-driven care: With hundreds of researchers and more than 1,000 clinical trials annually, we support an active research community that is shaping advancements in cancer care.
- Care from prevention to survivorship: Our approach covers the full spectrum of patient needs before, during, and after treatment. We apply evidence-based strategies to improve well-being and outcomes, supporting patients and their families throughout their cancer journey.
- Equity in cancer care: We are working to eliminate disparities and provide equitable access to cancer care and clinical research for all the communities we serve.
Massachusetts General Hospital and Brigham and Women’s Hospital, founding members of Mass General Brigham, are ranked by U.S. News & World Report as two of the nation's best hospitals for cancer care.
What is an institute at Mass General Brigham?
An institute at Mass General Brigham brings together specialized care, research, education, and community engagement into one unified framework. This model allows us to focus on advancing innovation within specific fields while fostering collaboration and community engagement to address complex health challenges.
This model is part of Mass General Brigham’s four-part mission to:
- Provide comprehensive patient care, from routine visits to complex cases, supporting our patients every step of the way.
- Lead the next era of research and medical discovery, advancing knowledge and developing innovative treatments that directly improve patient care.
- Recruit, support, and educate the next generation of leaders, strengthening the talent pipeline to meet current and future workforce needs.
- Strengthen local health through community partnerships, outreach programs, and investments in services that address the needs of the diverse communities we serve.
Our institutes work with clinicians, researchers, educators, and industry partners both within Mass General Brigham and beyond. Through collaboration and funding, we can expand our impact and deliver cutting-edge care.
Advancing cancer treatment through care, research, education, and community engagement
We care for more than your cancer. Our team supports your physical, emotional, and overall well-being throughout treatment and recovery. Through programs like Lifestyle Medicine, we offer personalized, evidence-based strategies to help improve your health, support treatment, and guide you through survivorship.
Mass General Brigham Cancer Institute is at the forefront of cancer research, leading to the advancement of new therapies. With clinicians and researchers working together, we’re making breakthroughs in areas like immunotherapy, AI, and personalized medicine.
As one of the nation’s leading cancer research enterprises, we conduct more than 1,000 active clinical trials each year and receive over $443 million in annual cancer research funding. Our discoveries transform science breakthroughs directly into care.
We’re advancing cancer treatment in key areas:
- Cellular therapy: We’re driving the evolution of immunotherapy. Our researchers achieved FDA approval for tumor-infiltrating lymphocyte (TIL) therapy to treat advanced melanoma, and they’re uncovering the promise of CAR T-cell therapy for glioblastoma, one of the most challenging cancers to treat.
- Artificial intelligence: AI has the potential to better detect side effects, identify biomarkers for lung cancer, and enhance how doctors talk to their patients about symptoms. We’re leading the way in AI-driven cancer care through innovative projects powered by large language models.
- Treatment after cancer surgery: Our researchers helped develop a breakthrough blood test that identifies any cancer cells remaining after surgery, offering faster and more precise treatment.
As home to the largest team of cancer specialists in New England, we are training the next generation of leaders and advancing research-driven treatments that improve outcomes for people everywhere.
Mass General Brigham Cancer Institute is a national hub for cancer education. Here, the next generation of cancer experts trains under some of the brightest minds in cancer medicine, contributing to leading research and gaining the firsthand experience offering patients with cancer the latest and most advanced treatments and technologies.
Cancer Institute locations extend throughout New England and includes two academic medical centers and multiple community-based hospitals. Our experienced cancer teams deliver high-quality cancer care in all locations, providing patients with comprehensive, community-based care and access to the expertise of world-renowned cancer specialists.
As part of Mass General Brigham, providers and patients benefit from coordination across locations and specialties. Shared electronic health records, dedicated care navigators, digital tools, and patient-facing apps support continuity of care.
Providers are also able to offer patients access to clinical trials and emerging therapies, as new treatments are continually researched, developed, and tested across our academic medical centers and research institutions, offering options that may not be widely available elsewhere.
Cancer Institute leadership
President
Executive Director, Center for Tumors of the Nervous System
Radiation Oncologist-in-Chief
Physician-in-Chief
Surgeon-in-Chief
Scientific Director
Join us
Top-tier cancer facilities for patients
We are enhancing our facilities to be flexible, modern spaces that are home to the Mass General Brigham Cancer Institute. Designed with flexibility, flow, and outstanding care in mind, these environments bring teams together and put patients first.
Guided by shared design principles, we’re building spaces that are consistent and exceptional across our extensive network of owned and affiliated sites—so that every patient receives the same exceptional care.
Enhancing our facilities where we offer care
- Mass General Brigham Healthcare Center in Waltham: The first phase of our ambulatory expansion in Waltham is complete. 11 new exam rooms opened in early 2026.
- Hale Building: Renovations to the Hale Building at our Brigham and Women’s Hospital campus will give us three floors dedicated to treating cancer, with infusion and multidisciplinary capabilities.
- Brigham and Women’s Faulkner Hospital: We are working on renovations to the fourth floor, which will include an infusion unit and multidisciplinary ambulatory clinics.
- Herb Chambers Tower: Located within the Phillip and Susan Ragon building at our Massachusetts General Hospital campus, this new space will be operational by 2027. The tower will include four inpatient floors and 60 exam rooms dedicated to cancer care services, along with 56 infusion chairs and a 24/7 oncology observation unit.
Collaborative cancer care
Our team model
Contact the Cancer Institute
855-776-4224
Call the Cancer Institute at 855-776-4224
International Patient Services
Contact information for international patients